- Rank375
- Previous Rank454
- CEOGeorge A. Scangos
- Address225 Binney St., Cambridge, MA 02142
- Websitewww.biogenidec.com
Key Financials
| $ Millions | % change | |
|---|---|---|
| Revenues | 6,932 | 25.7 |
| Profits | 1862 | 34.9 |
| Total Assets | 11,863 | - |
| Total Shareholder Equity | 8,620 | - |
| Market Value (on March 31, 2014) | 72,305 | - |
Profit as a % of
| Sales | 26.9 |
| Assets | 15.7 |
| Stockholders' Equity | 21.6 |
Earnings Per Share
| Earnings Per Share ($) | 7.81 |
| EPS % Change (from 2012) | 35.6 |
| EPS % Change (5 year) | 24.1 |
| EPS % Change (10 year) | - |
Total Return to Investors
| Total Return to Investors | 91 |
| Total Return to Investors (5 year, annualized) | 42.5 |
| Total Return to Investors (10 year, annualized) | 22.5 |